By Professor Sallie Pearson

Journal articles

de Oliveira Costa J; Pearson SA; Brieger D; Lujic S; Shawon MSR; Jorm LR; van Gool K; Falster MO, 2023, 'In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals', International Journal for Equity in Health, 22, pp. 226, http://dx.doi.org/10.1186/s12939-023-02030-1

Liu B; Stepien S; Dobbins T; Gidding H; Henry D; Korda R; Mills L; Pearson SA; Pratt N; Vajdic CM; Welsh J; Macartney K, 2023, 'Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study', Lancet Regional Health Western Pacific, 40, http://dx.doi.org/10.1016/j.lanwpc.2023.100928

Brett J; Gillies MB; Buckley NA; Pearson SA; Zoega H, 2023, 'Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?', British Journal of Clinical Pharmacology, 89, pp. 3411 - 3420, http://dx.doi.org/10.1111/bcp.15821

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older', Cancer Epidemiology, 86, http://dx.doi.org/10.1016/j.canep.2023.102444

Daniels B; Aslam M; van Leeuwen MT; Brown M; Hunt L; Gurney H; Tang M; Pearson SA; Vajdic CM, 2023, 'Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study', Lancet Regional Health Western Pacific, 39, pp. 100872, http://dx.doi.org/10.1016/j.lanwpc.2023.100872

Hansford HJ; Cashin AG; Jones MD; Swanson SA; Islam N; Douglas SRG; Rizzo RRN; Devonshire JJ; Williams SA; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sterne JAC; Sharp MK; Stuart EA; Hernán MA; Lee H; McAuley JH, 2023, 'Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review', JAMA Network Open, 6, pp. E2336023, http://dx.doi.org/10.1001/jamanetworkopen.2023.36023

Hansford HJ; Cashin AG; Jones MD; Swanson SA; Islam N; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sterne J; Sharp MK; Stuart EA; Hernan MA; Lee H; McAuley JH, 2023, 'Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline', BMJ Open, 13, pp. e074626, http://dx.doi.org/10.1136/bmjopen-2023-074626

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Sotade OT; Falster MO; Pearson SA; Jorm LR; Sedrakyan A, 2023, 'Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years', Journal of Thoracic and Cardiovascular Surgery, 166, pp. 728 - 737.e13, http://dx.doi.org/10.1016/j.jtcvs.2022.01.016

Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L, 2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669

Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675

Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL, 2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69, http://dx.doi.org/10.5694/mja2.51985

Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO; de Oliveira Costa J, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264

Robijn AL; Filion KB; Woodward M; Hsu B; Chow CK; Pearson SA; Jorm L; Falster MO; Havard A, 2023, 'Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events', Heart, 109, pp. 1016 - 1024, http://dx.doi.org/10.1136/heartjnl-2022-322170

Bruno C; Zoega H; Gillies MB; Havard A; Coghill D; Pearson SA; Brett J, 2023, 'Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis', Australian and New Zealand Journal of Psychiatry, 57, pp. 1073 - 1076, http://dx.doi.org/10.1177/00048674231170556

Wilson BE; Booth CM; Sullivan R; Aggarwal A; Sengar M; Jacob S; Bray F; Barton MB; Pearson SA, 2023, 'Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement', Lancet Oncology, 24, pp. 682 - 690, http://dx.doi.org/10.1016/S1470-2045(23)00183-3

Tang M; Daniels B; Coory M; Pearson SA, 2023, 'Timely and comprehensive real-world data for optimizing lung cancer treatment and outcomes for Australians', Asia Pacific Journal of Clinical Oncology, 19, pp. 413 - 414, http://dx.doi.org/10.1111/ajco.13874

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Bruno C; Havard A; Gillies MB; Coghill D; Brett J; Guastella AJ; Pearson SA; Zoega H, 2023, 'Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)', Australian and New Zealand Journal of Psychiatry, 57, pp. 675 - 685, http://dx.doi.org/10.1177/00048674221114782

de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA, 2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553, http://dx.doi.org/10.1111/bcp.15614

Bharat C; Degenhardt L; Pearson SA; Buizen L; Wilson A; Dobbins T; Gisev N, 2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567

Lopez D; Strange C; Sanfilippo F; Daniels B; Pearson S; Preen D, 2023, 'Priorities for building Australian workforce capacity to leverage population-based, routinely collected data: views from pharmacoepidemiology', Public Health Research and Practice, 33, http://dx.doi.org/10.17061/phrp32122206

Tang M; Pearson SA; Simes RJ; Chua BH, 2023, 'Harnessing Real-World Evidence to Advance Cancer Research', Current Oncology, 30, pp. 1844 - 1859, http://dx.doi.org/10.3390/curroncol30020143

Spilsbury K; Tuesley KM; Pearson SA; Coory MD; Donovan P; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Perioperative Beta-Blocker Supply and Survival in Women with Epithelial Ovarian Cancer and a History of Cardiovascular Conditions', Journal of Clinical Oncology, 41, pp. 266 - 275, http://dx.doi.org/10.1200/JCO.22.00097

Ahmed S; Pollack A; Havard A; Pearson SA; Chidwick K, 2023, 'Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance', International Journal of Population Data Science, 8, http://dx.doi.org/10.23889/ijpds.v8i1.2118

Robijn AL; Woodward M; Pearson SA; Hsu B; Chow CK; Filion KB; Jorm L; Havard A, 2022, 'Uptake of prescription smoking cessation pharmacotherapies after hospitalization for major cardiovascular disease', European journal of preventive cardiology, 29, pp. 2173 - 2182, http://dx.doi.org/10.1093/eurjpc/zwac172

Ali S; Na R; Tuesley K; Spilsbury K; Stewart LM; Coory M; Webb PM; Donovan P; Pearson SA; Jordan SJ; Neale RE, 2022, 'The association between diabetes mellitus of different durations and risk of pancreatic cancer: an Australian national data-linkage study in women', Cancer Epidemiology, 81, http://dx.doi.org/10.1016/j.canep.2022.102266

Crepalde-Ribeiro K; de Oliveira Costa J; Pearson SA; Silveira MR; Mendes JC; dos Santos SF; Cruz MA; Braga MDG, 2022, 'Trends in HIV post-exposure prophylaxis following sexual exposure in Brazil (2011–2019)', AIDS and Behavior, 26, pp. 4115 - 4125, http://dx.doi.org/10.1007/s10461-022-03737-y

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Lord SJ; Daniels B; Kiely BE; O'Connell DL; Beith J; Pearson S; Chiew KL; Bulsara MK; Houssami N, 2022, 'Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study', Medical Journal of Australia, 217, pp. 402 - 409, http://dx.doi.org/10.5694/mja2.51687

Camacho X; Zoega H; Gomes T; Schaffer AL; Henry D; Pearson S-A; Vigod S; Havard A, 2022, 'The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions.', International Journal of Epidemiology, 52, pp. 190 - 202, http://dx.doi.org/10.1093/ije/dyac180

Liu Y; Xiao S; Yin X; Gao P; Wu J; Xiong S; Hockham C; Hone T; Wu JHY; Pearson SA; Neal B; Tian M, 2022, 'Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review', Public Health Reviews, 43, pp. 1605025, http://dx.doi.org/10.3389/phrs.2022.1605025

de Oliveira Costa J; Pearson SA; Donnolley N; Bailey B; Hollingworth S; Stanford T; Pratt N, 2022, 'Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?', Pharmacoepidemiology and Drug Safety, 31, pp. 1010 - 1012, http://dx.doi.org/10.1002/pds.5450

Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA, 2022, 'Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children', Paediatric and Perinatal Epidemiology, 36, pp. 726 - 737, http://dx.doi.org/10.1111/ppe.12870

Camacho X; Schaffer A; Buckley N; Pratt N; Brett J; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilisation of sustained-release tapentadol in Australia.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1978

Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella AJ; Pearson SA; Zoega H, 2022, 'Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies', Journal of Child and Adolescent Psychopharmacology, 32, pp. 349 - 357, http://dx.doi.org/10.1089/cap.2022.0032

Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA, 2022, 'Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients', Heart Lung and Circulation, 31, pp. 1144 - 1152, http://dx.doi.org/10.1016/j.hlc.2022.04.048

Wilson BE; Pearson SA; Barton MB; Amir E, 2022, 'Regional Variations in Clinical Trial Outcomes in Oncology', Jnccn Journal of the National Comprehensive Cancer Network, 20, pp. 879 - 886, http://dx.doi.org/10.6004/jnccn.2022.7029

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson S-A; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022)', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 114, pp. 1206 - 1206, http://dx.doi.org/10.1093/jnci/djac118

Schaffer AL; Henry D; Zoega H; Elliott JH; Pearson SA, 2022, 'Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID- 19 pandemic in Australia', Plos One, 17, pp. e0269482, http://dx.doi.org/10.1371/journal.pone.0269482

Morrow RL; Mintzes B; Souverein PC; Hallgreen CE; Ahmed B; Roughead EE; De Bruin ML; Kristiansen SB; Lexchin J; Kemp-Casey A; Sketris I; Mangin D; Pearson SA; Puil L; Lopert R; Bero L; Gnjidic D; Sarpatwari A; Dormuth CR, 2022, 'Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study', Drug Safety, 45, pp. 623 - 638, http://dx.doi.org/10.1007/s40264-022-01175-2

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson SA; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older', Journal of the National Cancer Institute, 114, pp. 878 - 884, http://dx.doi.org/10.1093/jnci/djac050

Tuesley KM; Webb PM; Protani MM; Spilsbury K; Pearson S-A; Coory MD; Donovan P; Steer C; Stewart LM; Pandeya N; Jordan SJ, 2022, 'Response to Lehrer and Rheinstein', JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, http://dx.doi.org/10.1093/jnci/djac083

Chalmers K; Elshaug AG; Pearson SA; Landon BE, 2022, 'Patterns of specialist out-of-pocket costs for Australian Medicare services: Implications for price transparency', Australian Health Review, 46, pp. 645 - 651, http://dx.doi.org/10.1071/AH21316

Tang M; Lee CK; Lewis CR; Boyer M; Brown B; Schaffer A; Pearson SA; Simes RJ, 2022, 'Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer', Lung Cancer, 166, pp. 40 - 48, http://dx.doi.org/10.1016/j.lungcan.2022.01.024

de Oliveira Costa J; Zhao Y; Pearson S; Schaffer A, 2022, 'Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report', AIDS Care: psychological and socio-medical aspects of AIDS-HIV, 35, pp. 970 - 975, http://dx.doi.org/10.1080/09540121.2022.2050179

Gillies MB; Burgner DP; Ivancic L; Nassar N; Miller JE; Sullivan SG; Todd IMF; Pearson SA; Schaffer AL; Zoega H, 2022, 'Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship', British Journal of Clinical Pharmacology, 88, pp. 1143 - 1151, http://dx.doi.org/10.1111/bcp.15000

Morrow RL; Mintzes B; Souverein PC; De Bruin ML; Roughead EE; Lexchin J; Kemp-Casey A; Puil L; Sketris I; Mangin D; Hallgreen CE; Pearson SA; Lopert R; Bero L; Ofori-Asenso R; Gnjidic D; Sarpatwari A; Perry LT; Dormuth CR, 2022, 'Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis', BMJ Quality and Safety, 31, pp. 179 - 190, http://dx.doi.org/10.1136/bmjqs-2021-013910

Back to profile page